NasdaqCM - Delayed Quote USD
Galecto, Inc. (GLTO)
3.0400
+0.0500
+(1.67%)
At close: May 5 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-18,623
-18,623
-36,911
-42,932
-52,308
Investing Cash Flow
11,650
11,650
22,330
12,384
-48,048
Financing Cash Flow
--
--
2,876
507
--
End Cash Position
14,175
14,175
21,465
32,786
62,563
Capital Expenditure
--
--
--
-196
-223
Issuance of Capital Stock
--
--
2,876
507
--
Free Cash Flow
-18,623
-18,623
-36,911
-43,128
-52,531
12/31/2021 - 10/29/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HLVX HilleVax, Inc.
1.9200
-2.04%
EPIX ESSA Pharma Inc.
1.7100
-1.16%
SPRO Spero Therapeutics, Inc.
0.6100
-5.72%
ANTX AN2 Therapeutics, Inc.
1.2000
-1.64%
KZR Kezar Life Sciences, Inc.
4.3000
-4.44%
LVTX LAVA Therapeutics N.V.
1.2400
-3.12%
CLRB Cellectar Biosciences, Inc.
0.2661
-1.70%
KROS Keros Therapeutics, Inc.
14.56
-0.65%
RPTX Repare Therapeutics Inc.
1.4000
-2.10%
ASMB Assembly Biosciences, Inc.
14.13
-0.35%